These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19050730)

  • 1. Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories.
    Camajova J; Berwouts S; Matthijs G; Macek M; Dequeker E
    Eur J Hum Genet; 2009 Apr; 17(4):537-40. PubMed ID: 19050730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
    Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
    Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology.
    Lucarelli M; Porcaro L; Biffignandi A; Costantino L; Giannone V; Alberti L; Bruno SM; Corbetta C; Torresani E; Colombo C; Seia M
    J Mol Diagn; 2017 Sep; 19(5):788-800. PubMed ID: 28736296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory reporting on the clinical spectrum of CFTR p.Arg117His: Still room for improvement.
    Laudus N; Audrézet MP; Girodon E; Morris MA; Radojkovic D; Raynal C; Seia M; Štambergová A; Torkler H; Yamamoto R; Dequeker EMC
    J Cyst Fibros; 2020 Nov; 19(6):969-974. PubMed ID: 32505523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment.
    Dequeker E; Cassiman JJ
    Eur J Hum Genet; 1998; 6(2):165-75. PubMed ID: 9781062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verification of performance specifications of a molecular test: cystic fibrosis carrier testing using the Luminex liquid bead array.
    Lacbawan FL; Weck KE; Kant JA; Feldman GL; Schrijver I;
    Arch Pathol Lab Med; 2012 Jan; 136(1):14-9. PubMed ID: 22208482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology.
    Bergougnoux A; D'Argenio V; Sollfrank S; Verneau F; Telese A; Postiglione I; Lackner KJ; Claustres M; Castaldo G; Rossman H; Salvatore F; Raynal C
    Clin Chem Lab Med; 2018 Jun; 56(7):1046-1053. PubMed ID: 29427548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges in cystic fibrosis screening.
    Lyon E; Miller C
    Arch Pathol Lab Med; 2003 Sep; 127(9):1133-9. PubMed ID: 12946232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis.
    Brinson EC; Adriano T; Bloch W; Brown CL; Chang CC; Chen J; Eggerding FA; Grossman PD; Iovannisci DM; Madonik AM; Sherman DG; Tam RW; Winn-Deen ES; Woo SL; Fung S
    Genet Test; 1997; 1(1):61-8. PubMed ID: 10464627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing and quality control in diagnostic laboratories.
    Dequeker E; Cassiman JJ
    Nat Genet; 2000 Jul; 25(3):259-60. PubMed ID: 10888869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnostics.
    Soltysova A; Tothova Tarova E; Ficek A; Baldovic M; Polakova H; Kayserova H; Kadasi L
    Clin Respir J; 2018 Mar; 12(3):1197-1206. PubMed ID: 28544683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.
    Dequeker E; Stuhrmann M; Morris MA; Casals T; Castellani C; Claustres M; Cuppens H; des Georges M; Ferec C; Macek M; Pignatti PF; Scheffer H; Schwartz M; Witt M; Schwarz M; Girodon E
    Eur J Hum Genet; 2009 Jan; 17(1):51-65. PubMed ID: 18685558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
    Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
    Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of cystic fibrosis in Lithuania: incomplete CFTR mutation detection by PCR-based screening protocols.
    Giannattasio S; Bobba A; Jurgelevicius V; Vacca RA; Lattanzio P; Merafina RS; Utkus A; Kucinskas V; Marra E
    Genet Test; 2006; 10(3):169-73. PubMed ID: 17020467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing strategies for CFTR molecular testing.
    Gimenez J; Ramos MD; Casals T
    J Cyst Fibros; 2011 Mar; 10(2):143-4. PubMed ID: 21147553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.